 |
|
Aspirin in the Treatment of Type 2 Diabetes
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Men and women with type 2 diabetes mellitus have a shorter life expectancy than those without diabetes,1 and deaths from heart disease and stroke are more frequent in diabetics than in nondiabetics.2 While mortality from heart disease is declining in the general US population, the same is not true among diabetic subjects.3 The editorial by Fagan et al4 that addressed these greater cardiovascular risks and the currently available therapeutic benefits in type 2 diabetes emphasized blood pressure reduction, lowering of elevated low-density lipoprotein cholesterol, and maintaining optimum blood sugar levels.4 However, along with their recommendation that aspirin therapy should be used "in diabetic persons with any evidence of cardiovascular disease unless absolutely contradicted," the authors should have provided more details, since this is an important therapeutic initiative.
The use of aspirin to treat type 2 diabetes has been shown to be of benefit in several published reports.5-6 Harpaz and colleagues7 . . . [Full Text of this Article]
RELATED LETTER
Aspirin in Diabetes: Beware of Retinopathy
H. T. Ong and Samuel K. Kajubi
Arch Intern Med. 2000;160(19):3004.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The Cost-Effectiveness of Counseling Strategies to Improve Adherence to Highly Active Antiretroviral Therapy among Men Who Have Sex with Men
Zaric et al.
Med Decis Making 2008;28:359-376.
ABSTRACT
Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy
Sanders et al.
NEJM 2005;352:570-585.
ABSTRACT
| FULL TEXT
Aspirin in Diabetes: Beware of Retinopathy
Ong and Kajubi
Arch Intern Med 2000;160:3004-3004.
FULL TEXT
|
